DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neupogen (Filgrastim) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (34)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neupogen (Filgrastim) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 34   Next >>

Possible Neupogen side effects in 45 year old female

Reported by a physician from India on 2012-07-20

Patient: 45 year old female

Reactions: Thrombocytosis, Deep Vein Thrombosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neupogen

Other drugs received by patient: Aripiprazole



Possible Neupogen side effects in 58 year old male

Reported by a physician from Czech Republic on 2012-06-14

Patient: 58 year old male

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neupogen



Possible Neupogen side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28

Patient: male

Reactions: Foetal Distress Syndrome, Premature Delivery

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Etoposide
    Indication: Neuroblastoma

Neupogen
    Indication: Neuroblastoma

Cisplatin
    Indication: Neuroblastoma



Possible Neupogen side effects in 71 year old male

Reported by a physician from Japan on 2012-05-10

Patient: 71 year old male

Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Anaemia, Platelet Count Decreased, Pleural Effusion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Sprycel
    Dosage: 70 mg, 2x/day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-22

Neupogen
    Indication: Acute Lymphocytic Leukaemia

Oncovin
    Indication: Acute Lymphocytic Leukaemia

Idarubicin HCL
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-08
    End date: 2012-02-15

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-08
    End date: 2012-02-15

Other drugs received by patient: Candesartan Cilexetil; Dexamethasone Sodium Phosphate; Fluconazole; Allopurinol; Polymyxin B Sulfate; Cotrim; Neutrogin



Possible Neupogen side effects in 46 year old female

Reported by a physician from Brazil on 2012-05-01

Patient: 46 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Agranulocytosis, Diabetes Mellitus, Hypothyroidism, Diabetic Ketoacidosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 mug, qwk
    Indication: Hepatitis C
    Start date: 2011-04-28
    End date: 2012-02-16

Neupogen
    Dosage: unk, qwk
    Indication: Agranulocytosis
    Start date: 2011-06-02
    End date: 2012-02-19

Other drugs received by patient: Ribavirin



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-24

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Administration route: Oral
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Citalopram Hydrobromide; Pirenzepine; Amisulpride



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-03

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Agranulocytosis, Sepsis, Neutropenia, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 110 mg milligram(s),intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg milligram(s)intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s)intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg milligram(s) ( 1 day ) oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Clozapine
    Dosage: 200 mg milligram(s) ( 1 day ) oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Other drugs received by patient: Citalopram Hydrobromide



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-27

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutrophil Count Increased, Neutropenia, Deep Vein Thrombosis, White Blood Cell Count Increased, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg mgilligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mgilligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg mgilligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Citalopram Hydrobromide; (Amisulpride); (Pirenzepine)



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-15

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-12

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-09

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Agranulocytosis, Blood Disorder, Neutropenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Neupogen
    Dosage: 800 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Doxorubicin HCL
    Dosage: 110 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Citalopram Hydrobromide; Pirenzepine; Amisulpride



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-02

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 2 mg milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Doxorubicin HCL
    Dosage: 110 mg milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Cyclophosphamide
    Dosage: 1600 milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s), unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-01-12

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Clozapine
    Start date: 2011-12-02

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-23

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-09-22

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 88 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-23

Patient: 88 year old male

Reactions: White Blood Cell Count Decreased, Respiratory Distress

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neupogen

Other drugs received by patient: Ativan; Pepcid; Solu-Cortef; Iron; Keppra; Synthroid; Folic Acid; Seroquel; Colymycin / 00013206 /; Plaquenil; Miralax / 00754501 /; Proscar; Haldol; Vitamin B6



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-22

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Agranulocytosis, Neutropenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23



Possible Neupogen side effects in 42 year old male

Reported by a pharmacist from United Kingdom on 2012-02-21

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 110 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Neupogen
    Dosage: 800 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Prednisolone
    Dosage: 60 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Vincristine
    Dosage: 2 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-30

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Agranulocytosis, Neutropenia, Diffuse Large B-Cell Lymphoma, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg milligram(s) intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Doxorubicin HCL
    Dosage: 110 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: (Pirenzeprine); (Citalopram); (Amisulpride)



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-26

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-23

Clozapine
    Start date: 2011-12-02

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-09-22

Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-01-12

Other drugs received by patient: Amisulpride; Citalopram Hydrobromide; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a pharmacist from United Kingdom on 2012-01-23

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Cyclophosphamide
    Dosage: 1600 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine
    Dosage: 2 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Sepsis, Bone Marrow Failure, non-Hodgkin's Lymphoma, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Doxorubicin HCL
    Dosage: 2 mg milligram(s), unknown intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Pirenzepine; Citalopram Hydrobromide; Amisulpride



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Agranulocytosis, Neutropenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 800 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Prednisolone
    Dosage: 60 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-17

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Agranulocytosis, Neutropenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Cyclophosphamide
    Dosage: 1600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Prednisolone
    Dosage: 60 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-17

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-16

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 800 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Cyclophosphamide
    Dosage: 1600 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine
    Dosage: 2 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Amisulpride; Citalopram; Pirenzepine



Possible Neupogen side effects in 43 year old male

Reported by a physician from Netherlands on 2012-01-05

Patient: 43 year old male, weighing 78.0 kg (171.6 pounds)

Reactions: Embolism

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Rituximab
    Dosage: 750 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-09-01

Vincristine
    Dosage: 2 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-09-01

Neupogen
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-09-02

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2011-09-01

Doxorubicin HCL
    Dosage: 105 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-09-01

Cyclophosphamide
    Dosage: 575 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-09-01

Vincristine
    Dosage: 1 mg, unk



Possible Neupogen side effects in 42 year old male

Reported by a pharmacist from United Kingdom on 2012-01-04

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-23

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Clozapine
    Start date: 2011-12-02

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-09-22

Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-01-12

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017